针对IgE:在过敏性疾病中开发药物
Xiao-Jing Ling1, Ji-Fu Wei1, Ying Zhu2
1Department of Pharmacy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
International immunopharmacology
|June 22, 2023
概括
由免疫球蛋白E (IgE) 驱动的过敏性疾病在全球范围内正在上升. 针对IgE和记忆B细胞的新疗法为更好地控制这些免疫系统疾病提供了希望.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 治疗策略 治疗策略
背景情况:
- 皮肤炎,鼻炎,喘和食物过敏等过敏性疾病在全球范围内越来越多,这对公众健康构成了重大挑战.
- 免疫球蛋白E (IgE) 在调解常见的过敏疾病方面发挥着中心作用,通过与其在巨细胞和基细胞上的高亲和受体 (FcεRI) 以及其低亲和受体 (CD23) 的相互作用.
研究的目的:
- 审查目前旨在干扰免疫球蛋白E (IgE) 在过敏疾病管理中的治疗策略.
- 探索新的方法,包括针对记忆B细胞,以更有效地控制过敏症.
主要方法:
- 关于IgE介导过敏疾病和当前治疗干预措施的现有文献的全面审查.
- 对IgE在过敏反应和免疫细胞调节中的作用背后的机制的分析.
- 讨论着重于记忆B细胞和多目标药物开发的新兴策略.
主要成果:
- IgE与FcεRI和CD23相互作用,启动信号级联,导致巨细胞和基细胞的激活,并调节免疫反应.
- 针对IgE的各种治疗策略正在开发中,并在过敏性疾病治疗方面获得了关注.
结论:
- 准记忆B细胞,包括长寿等离子体细胞和IgE+记忆B细胞,可能为完全控制过敏疾病提供了一条途径.
- 开发具有对多个点协同作用的药物是一种有前途的方法,可以提高系统性过敏疾病的治疗疗效.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
357
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
357
01:27Allergic Drug Reactions
898
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
898
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
02:06Allergic Reactions
27.8K
Overview
27.8K
01:10Antibody Structure
60.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.4K
01:17Drugs Used in Lower Respiratory Disorders: Overview
504
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
504